MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation (original) (raw)

• Kyriakis, J.M. in Protein Kinase Functions (ed. Woodgett, J.R.) 40–156 (Oxford University Press, Oxford, 2000).
  Google Scholar
• Wojnowski, L. et al. Endothelial apoptosis in Braf-deficient mice. Nature Genet. 16, 293–297 (1997).
  Article CAS Google Scholar
• Wojnowski, L. et al. Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. Mech. Dev. 91, 97–104 (2000).
  Article CAS Google Scholar
• Gallo, K.A. & Johnson, G.L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nature Rev. Mol. Cell. Biol. 3, 663–672 (2002).
  Article CAS Google Scholar
• Sathyanarayana, P. et al. Activation of the Drosophila MLK by ceramide reveals TNF-α and ceramide as agonists of mammalian MLK3. Mol. Cell 10, 1527–1533 (2002).
  Article CAS Google Scholar
• Shen, Y.H. et al. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J. Biol. Chem. 278, 26715–26721 (2003).
  Article CAS Google Scholar
• Zhang, B.-H. & Guan, K.-L. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J. 19, 5429–5439 (2000).
  Article CAS Google Scholar
• Chong, H., Lee, J. & Guan, K.-L. Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J. 20, 3716–3727 (2001).
  Article CAS Google Scholar
• Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002).
  Article CAS Google Scholar
• Malumbres, M. & Barbacid, M. RAS oncogenes: the first 30 years. Nature Rev. Cancer 3, 459–465 (2003).
  Article CAS Google Scholar
• McCormick, F. Activators and effectors of ras p21 proteins. Curr. Opin. Genet. Dev. 4, 71–76 (1994).
  Article CAS Google Scholar
• Marshall, C.J. Ras effectors. Curr. Opin. Cell Biol. 8, 197–204 (1996).
  Article CAS Google Scholar
• Downward, J. Targeting RAS signalling pathways in cancer therapy. Nature Rev. Cancer. 3, 11–22 (2003).
  Article CAS Google Scholar
• Cichowski, K. & Jacks, T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593–604 (2001).
  Article CAS Google Scholar
• Lynch, T.M. & Gutmann, D.H. Neurofibromatosis 1. 20, 841–865 (2002).
• Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
  Article CAS Google Scholar
• Chi, J.T. et al. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl Acad. Sci. USA. 100, 6343–6346 (2003).
  Article CAS Google Scholar
• Semizarov, D. et al. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl Acad. Sci. USA. 100, 6347–6352 (2003).
  Article CAS Google Scholar
• Kyriakis, J.M. et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156–160 (1994).
  Article CAS Google Scholar
• Dumitru, C.D. et al. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl-2/ERK-dependent pathway. Cell 103, 1071–1083 (2000).
  Article CAS Google Scholar
• Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. & Williams, B.R.G. Activation of the interferon system by short-interfering RNAs. Nature Cell Biol. 5, 834–839 (2003).
  Article CAS Google Scholar
• Wan, P.T.C. et al. Mechanism of activation of the Raf-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855–867 (2004).
  Article CAS Google Scholar
• Mercer, K.E. & Pritchard, C.A. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta 1653, 25–40 (2003).
  CAS PubMed Google Scholar
• Mansour, S.J. et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966–970 (1994).
  Article CAS Google Scholar
• Lavoie, J.N., L'Allemain, G., Brunet, A., Müller, R. & Pouysségur, J. Cyclin D1 expression is regulated positively by the p42/p44 MAPK and negatively by the p38/HOG MAPK pathway. J. Biol. Chem. 271, 20608–20616 (1996).
  Article CAS Google Scholar
• Brunet, A. et al. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664–674 (1999).
  Article CAS Google Scholar
• Balmanno, K. & Cook, S.J. Sustained MAP kinase activation is required for the expression of cyclin D1, p21 Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18, 3085–3097 (1999).
  Article CAS Google Scholar
• Swenson, K.I., Winkler, K.E. & Means, A.R. A new identity for MLK3 as a NIMA-related, cell cycle-regulated kinase that is localized near centrosomes and influences microtubule organization. Mol. Biol. Cell 14, 156–172 (2003).
  Article CAS Google Scholar
• Sherr, C.J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689–3695 (2000).
  CAS Google Scholar
• McClatchey, A.I. Merlin and ERM proteins: unappreciated roles in cancer development? Nature Rev. Cancer 3, 877–883 (2003).
  Article Google Scholar